- Home
- ZYME vs GNL Comparison
ZYME vs GNL Comparison
Compare ZYME & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZYME | GNL |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZYME | GNL |
|---|---|---|
| Price | $25.80 | $8.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $28.50 | $9.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 9.20% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $134,481,000.00 | ★ $751,333,000.00 |
| Revenue This Year | $64.45 | N/A |
| Revenue Next Year | $67.04 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 116.21 | 17.63 |
| 52 Week Low | $9.03 | $6.51 |
| 52 Week High | $28.49 | $8.38 |
Technical Indicators
Market Signals| Indicator | ZYME | GNL |
|---|---|---|
| Relative Strength Index (RSI) | 63.18 | 61.51 |
| Support Level | $24.83 | $8.05 |
| Resistance Level | $27.49 | $8.26 |
| Average True Range (ATR) | 1.32 | 0.14 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 60.00 | 86.97 |
Price Performance
Historical ComparisonAbout ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.